CELGENE - KOUSTENI LPA (Private)

Jun 1 2019 - May 30 2022

GENETIC CHARACTERIZATION OF OSTEOBLAST-INDUCED LEUKEMIAS (Federal Gov)

Sep 1 2016 - Jun 30 2020

HORMONES: BIOCHEMISTRY AND MOLECULAR BIOLOGY (Federal Gov)

Jul 1 2015 - Jun 30 2020

THE DIALOGUE BETWEEN BONE AND THE BRAIN: ENDOCRINE AND MOLECULAR BASES (Federal Gov)

Aug 1 2010 - Apr 30 2020

BIOLOGY AND THERAPEUTIC TARGETING OF THE CROSSTALK BETWEEN MDS AND STROMAL CELLS: ELUCIDATING THE INTERACTIONS AND IDENTIFYING CLINICAL TARGETS (Private)

Sep 1 2017 - Aug 31 2019

THE OSTEOBLAST AS A DETERMINANT OF LEUKEMOGENESIS (Federal Gov)

Aug 15 2013 - Jul 31 2018

BONE PROPERTIES IN HYPOPARATHYROIDISM: EFFECT OF PTH (Federal Gov)

Dec 1 2004 - Jun 30 2017

OSTEOPOROSIS IN HIV INFECTED POSTMENOPAUSAL WOMEN (Federal Gov)

Jul 1 2010 - Jun 30 2016

TARGETING THE OSTEOBLAST IN ACUTE MYELOGENOUS LEUKEMIA (Private)

Dec 1 2013 - Nov 30 2015

REGULATION OF BONE MASS BY PATHWAYS CONTROLLING LIFESPAN EXTENSION (Private)

Jan 1 2010 - Dec 31 2014

A POTENT ANTI-DIABETIC HORMONE DERIVED FROM OSTEOLASTS (Private)

Dec 11 2012 - Dec 10 2014

PRIMARY HYPERPARATHYROIDISM (Federal Gov)

Jul 1 1984 - Aug 31 2014

SIRTUIN/FOXO SIGNALING IN THE REGULATION OF BONE MASS (Federal Gov)

Sep 15 2008 - Apr 30 2014

DETECTING INTERACTIONS BETWEEN OSTEOBLASTS AND LEUKEMIA BLAS TS (Private)

Dec 1 2008 - Nov 30 2010